These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34071558)

  • 1. FSHD1 Diagnosis in a Russian Population Using a qPCR-Based Approach.
    Zernov NV; Guskova AA; Skoblov MY
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34071558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.
    Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL
    Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].
    Salort-Campana E; Nguyen K; Lévy N; Pouget J; Attarian S
    Rev Neurol (Paris); 2013; 169(8-9):573-82. PubMed ID: 24011979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.
    Rieken A; Bossler AD; Mathews KD; Moore SA
    Neurology; 2021 Feb; 96(7):e1054-e1062. PubMed ID: 33443126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD.
    Vasale J; Boyar F; Jocson M; Sulcova V; Chan P; Liaquat K; Hoffman C; Meservey M; Chang I; Tsao D; Hensley K; Liu Y; Owen R; Braastad C; Sun W; Walrafen P; Komatsu J; Wang JC; Bensimon A; Anguiano A; Jaremko M; Wang Z; Batish S; Strom C; Higgins J
    Neuromuscul Disord; 2015 Dec; 25(12):945-51. PubMed ID: 26420234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of single-molecule optical mapping to a multigeneration FSHD1 pedigree.
    Zhang Q; Xu X; Ding L; Li H; Xu C; Gong Y; Liu Y; Mu T; Leigh D; Cram DS; Tang S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e565. PubMed ID: 30666819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.
    Jones TI; King OD; Himeda CL; Homma S; Chen JC; Beermann ML; Yan C; Emerson CP; Miller JB; Wagner KR; Jones PL
    Clin Epigenetics; 2015; 7(1):37. PubMed ID: 25904990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Identification of facioscapulohumeral muscular dystrophy 1 in two siblings with normal phenotypic parents using optical genome mapping.
    Jiang J; Cai X; Qu H; Yao Q; He T; Yang M; Zhou H; Zhang X
    Front Neurol; 2024; 15():1258831. PubMed ID: 38361638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2.
    Calandra P; Cascino I; Lemmers RJ; Galluzzi G; Teveroni E; Monforte M; Tasca G; Ricci E; Moretti F; van der Maarel SM; Deidda G
    J Med Genet; 2016 May; 53(5):348-55. PubMed ID: 26831754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2.
    Lemmers RJ; van der Vliet PJ; Balog J; Goeman JJ; Arindrarto W; Krom YD; Straasheijm KR; Debipersad RD; Özel G; Sowden J; Snider L; Mul K; Sacconi S; van Engelen B; Tapscott SJ; Tawil R; van der Maarel SM
    Eur J Hum Genet; 2018 Jan; 26(1):94-106. PubMed ID: 29162933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.
    Haynes P; Bomsztyk K; Miller DG
    Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.
    Lemmers RJLF; van der Vliet PJ; Vreijling JP; Henderson D; van der Stoep N; Voermans N; van Engelen B; Baas F; Sacconi S; Tawil R; van der Maarel SM
    Hum Mol Genet; 2018 Oct; 27(20):3488-3497. PubMed ID: 30281091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study.
    Wang Z; Qiu L; Lin M; Chen L; Zheng F; Lin L; Lin F; Ye Z; Lin X; He J; Wang L; Lin X; He Q; Chen W; Lin Y; Fu Y; Wang N
    Lancet Reg Health West Pac; 2022 Jan; 18():100323. PubMed ID: 35024656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing Copy Number Variation Using Pulsed-Field Gel Electrophoresis: Providing a Genetic Diagnosis for FSHD1.
    Lemmers RJ
    Methods Mol Biol; 2017; 1492():107-125. PubMed ID: 27822859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSHD1 and FSHD2 form a disease continuum.
    Sacconi S; Briand-Suleau A; Gros M; Baudoin C; Lemmers RJLF; Rondeau S; Lagha N; Nigumann P; Cambieri C; Puma A; Chapon F; Stojkovic T; Vial C; Bouhour F; Cao M; Pegoraro E; Petiot P; Behin A; Marc B; Eymard B; Echaniz-Laguna A; Laforet P; Salviati L; Jeanpierre M; Cristofari G; van der Maarel SM
    Neurology; 2019 May; 92(19):e2273-e2285. PubMed ID: 30979860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation.
    Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H
    Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex 4q35 and 10q26 Rearrangements: A Challenge for Molecular Diagnosis of Patients With Facioscapulohumeral Dystrophy.
    Delourme M; Charlene C; Gerard L; Ganne B; Perrin P; Vovan C; Bertaux K; Nguyen K; Bernard R; Magdinier F
    Neurol Genet; 2023 Jun; 9(3):e200076. PubMed ID: 37200893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and genetic characteristics of facioscapulohumeral muscular dystrophy Landuzi-Dezherina type 1].
    Dadali EL; Sharkova IV; Zernov NV; Rudenskaya GE; Skoblov MY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):122-128. PubMed ID: 29265097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.